- Scrip Originals
Brought to you by
GSK acquires sirtuin-targeting firm Sirtris for $720mm
16 May 2008
GlaxoSmithKline will tender $720mm in cash to acquire public start-up Sirtris Pharmaceuticals (sirtuin modulation drug development).
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com